How much did Aptadir Therapeutics raise?

Aptadir Therapeutics raised $45M at Seed, announced 29 September 2026.

Who founded Aptadir Therapeutics?

Giovanni Amabile is Founder & CEO of Aptadir Therapeutics.

What does Aptadir Therapeutics do?

Aptadir Therapeutics operates in HealthTech and is based in Italy.

FundedStartupsDaily / HealthTech / Aptadir Therapeutics

Aptadir Therapeutics raises $45M

Aptadir Therapeutics announced a Seed round of $45M on 29 September 2026. The company operates in HealthTech and is based in Italy. It was founded by Giovanni Amabile, Founder & CEO. Announced 6 days ago.

Raised

$45M

Stage

Seed

Industry

HealthTech

Country

Italy

Founder

Giovanni Amabile

Founder & CEO, Aptadir Therapeutics

LinkedIn profile aptadir.com

Outreach angles

-Giovanni Amabile founded and leads Aptadir, a Milan-based biotech building a new class of RNA inhibitors.
-Aptadir's DiRs technology builds on research from an international team in RNA/DNA biology and genetic disorders.
-The $45M seed led by 4BIO Capital with CDP Venture Capital targets Fragile X Syndrome first.